Princeton BioMeditech
About:
Princeton BioMeditech is a rapid, point-of-care diagnostics.
Website: http://www.pbmc.com/
Top Investors: U.S. Department of Defense, National Institute of Biomedical Imaging and Bioengineering, U.S. Department of Health & Human Services
Description:
Princeton BioMeditech is a rapid, point-of-care diagnostics. Utilizing its patented technologies, PBM has developed and introduced an extensive menu of over 70 different one-step/rapid tests.
Total Funding Amount:
$9.9M
Headquarters Location:
Monmouth Junction, New Jersey, United States
Founded Date:
1988-01-01
Founders:
Number of Employees:
Last Funding Date:
2024-04-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai